Unichem Laboratories Announces Financial Results for FY 2026 and Key Corporate Appointments
Unichem Laboratories Limited announced the outcomes of its Board of Directors meeting held on May 22, 2026. Key approvals included the re-designation and re-appointment of Mr. Pabitrakumar Bhattacharyya as Managing Director & Chief Executive Officer, alongside the confirmation of external auditors for the financial year 2026-27.The company also released its financial results, including Unaudited Financial Results for the quarter ended March 31, 2026, and Audited Financial Statements for the year ended March 31, 2026, both on a consolidated and standalone basis.
Leadership and Audit Appointments
At the Board meeting, the company approved the redesignation of Mr. Pabitrakumar Bhattacharyya from 'Managing Director' to 'Managing Director & Chief Executive Officer', effective from the date of the meeting. Furthermore, Mr. Bhattacharyya was re-appointed as Managing Director and Chief Executive Officer for a further period of three years, effective from August 10, 2026, through August 9, 2029.The Board also appointed new audit partners for the financial year 2026-27, based on the recommendation of the Audit Committee:
- M/s. Kishore Bhatia & Associates, Cost Accountants, were re-appointed as Cost Auditors for FY 2026-27.
- M/s. Ram Agarwal & Associates, Chartered Accountants, were re-appointed as Internal Auditors for the Company for FY 2026-27.
Financial Performance Highlights
The company released financial summaries for the fiscal year ending March 31, 2026.Consolidated Financial Results
The consolidated financial statements showed the following total income and profit metrics:| Metric | Year Ended March 31, 2026 (Audited) | Year Ended March 31, 2025 (Audited) |
|---|---|---|
| Revenue from Operations (₹ in Crores) | 2,201.85 | 2,110.97 |
| Total Income (₹ in Crores) | 2,264.91 | 2,146.29 |
| Total Expenses (₹ in Crores) | 2,174.39 | 1,991.70 |
| Profit/(Loss) for the period after tax (₹ in Crores) | 252.84 | 137.52 |
| Total Comprehensive Income/(Loss) (₹ in Crores) | 264.83 | 130.55 |
Standalone Financial Results
On a standalone basis, the company reported the following key financial movements:| Metric | Year Ended March 31, 2026 (Audited) | Year Ended March 31, 2025 (Audited) |
|---|---|---|
| Revenue from Operations (₹ in Crores) | 1,412.29 | 1,735.70 |
| Total Income (₹ in Crores) | 1,475.19 | 1,776.53 |
| Total Expenses (₹ in Crores) | 1,492.76 | 1,597.85 |
| Profit/(Loss) for the period after tax (₹ in Crores) | 158.94 | 162.96 |
| Total Comprehensive Income/(Loss) (₹ in Crores) | 166.54 | 163.06 |
Balance Sheet Snapshot
Comparing the consolidated total assets and liabilities for the two years shows a substantial shift in key components:| Item | As at March 31, 2026 (Audited) (₹ in Crores) | As at March 31, 2025 (Audited) (₹ in Crores) |
|---|---|---|
| TOTAL ASSETS | 3,737.44 | 3,569.40 |
| Property, plant and equipment (Non-current) | 1,135.90 | 1,211.01 |
| Inventories (Current) | 974.97 | 988.74 |
| Trade receivables (Current) | 828.58 | 778.81 |
| Cash and cash equivalents (Current) | 289.48 | 89.58 |
| TOTAL EQUITY AND LIABILITIES | 3,737.44 | 3,569.40 |
| Other equity (Non-current) | 2,703.36 | 2,436.51 |
| Borrowings (Non-current) (₹ in Crores) | 39.12 | 60.81 |
Cash Flow Activities
The net cash flow from operating activities for the year ended March 31, 2026, was 3.64 ₹ Crores, compared to a net cash flow of (7.02 ₹ Crores for the same period in 2025.| Activity Stream | Year Ended March 31, 2026 (₹ in Crores) | Year Ended March 31, 2025 (₹ in Crores) |
|---|---|---|
| Net Cash Flow from Operating Activities | 3.64 | (7.02) |
| Net Cash Flow from Investing Activities | -192.06 | -241.23 |
| Net Cash Flow from Financing Activities | 1.86 | 183.76 |
| Increase/(Decrease) in Cash and Cash Equivalents | 197.56 | (64.49) |
***
Note: Financial figures are presented in ₹ Crores.
UNICHEMLAB Stock Price Movement
On Friday, Unichem Laboratories Limited shares edged higher, closing at ₹370.85 after gaining 1.48% for the session. The stock finished the day with a volume of 41,152 shares, navigating a daily trading range between ₹364.65 and ₹379.65.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: